Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: a systematic review and metaanalysis of observational studies.
about
Colorectal cancer and dysplasia in inflammatory bowel diseaseCancer in inflammatory bowel diseaseColitis-associated colon cancer: Is it in your genes?Molecular cancer prevention: Current status and future directionsUlcerative colitis-associated colorectal cancerDifferential response of flat and polypoid colitis-associated colorectal neoplasias to chemopreventive agents and heterocyclic aminesMesalamine in the treatment and maintenance of remission of ulcerative colitisSystematic review with meta-analysis: the declining risk of colorectal cancer in ulcerative colitisUse of Cancer Stem Cells to Investigate the Pathogenesis of Colitis-associated CancerReview article: maintenance therapy in patients with ulcerative colitisMesalamine modulates intercellular adhesion through inhibition of p-21 activated kinase-1Oncogenic Smad3 signaling induced by chronic inflammation is an early event in ulcerative colitis-associated carcinogenesisColorectal Cancer and Dysplasia in Inflammatory Bowel Disease: A Review of Disease Epidemiology, Pathophysiology, and Management.Inflammation and disease duration have a cumulative effect on the risk of dysplasia and carcinoma in IBD: a case-control observational study based on registry data.The position of the amino group on the benzene ring is critical for mesalamine's improvement of replication fidelity.Histological healing favors lower risk of colon carcinoma in extensive ulcerative colitis.Mesalazine in inflammatory bowel disease: a trendy topic once again?In vivo effects of mesalazine or E. coli Nissle 1917 on microsatellite instability in ulcerative colitisDysplasia and cancer in inflammatory bowel disease.Oral administration of the anti-proliferative substance taurolidine has no impact on dextran sulfate sodium induced colitis-associated carcinogenesis in mice.Indications for 5-aminosalicylate in inflammatory bowel disease: is the body of evidence complete?New Research in Ulcerative Colitis: Optimizing 5-ASA Administration for Efficacy and Adherence5-ASA Dose-Response: Maximizing Efficacy and Adherence.Cost effectiveness of ulcerative colitis treatment in Germany: a comparison of two oral formulations of mesalazine.Cancer surveillance strategies in ulcerative colitis: the need for modernization.Current management of inflammatory bowel disease and colorectal cancer.Direct comparison of two different mesalamine formulations for the maintenance of remission in patients with ulcerative colitis: a double-blind, randomized study.Inflammatory Bowel Disease-related Colorectal Cancer in the Asia-Pacific Region: Past, Present, and FutureColitis and colorectal cancer.Anti-inflammatory effects of freeze-dried black raspberry powder in ulcerative colitisColorectal cancer in inflammatory bowel disease: the risk, pathogenesis, prevention and diagnosis.Antioxidant properties of mesalamine in colitis inhibit phosphoinositide 3-kinase signaling in progenitor cells.Current Controversies in Crohn's Disease: A Roundtable Discussion of the BRIDGe GroupFive-aminosalicylic Acid: an update for the reappraisal of an old drugPros and cons of medical management of ulcerative colitis.Use of confocal laser endomicroscopy to predict relapse of ulcerative colitis.Overexpression of PAK1 promotes cell survival in inflammatory bowel diseases and colitis-associated cancer.5-Aminosalicylates reduce the risk of colorectal neoplasia in patients with ulcerative colitis: an updated meta-analysisReview article: why, when and how to de-escalate therapy in inflammatory bowel diseases.Cancer and immunomodulators in inflammatory bowel diseases.
P2860
Q22241218-7B7AEC2D-B86B-4443-B4FB-6FEF3377AB73Q24648315-E7E480D6-FC8A-435B-8901-30A107912C23Q26778018-8450C0A2-6F8A-4973-A38E-C8D9BECB4950Q26797207-A43FD16D-48EC-4C2B-AB33-B3E77D5A9A99Q26822499-DA35D585-AE47-4816-A453-D5110CE88FF0Q26864562-5B716993-244F-4766-B73D-C77A658B5F95Q26865546-9684E8C7-8A5D-4961-AAB8-AE93522B7B26Q27011853-15C91DE3-76C9-4962-8044-36BA3811444CQ28079356-9F1DCD5E-1E7B-4A1A-9146-E3F77B6DE6BFQ28260710-609471C9-8B06-4017-BCBF-940A31961F46Q28279134-206B65C9-6677-44D2-B4C0-82B609DC7AC3Q28287002-58204C50-0119-4DB6-ABAE-258993EF9F48Q30245054-30899853-ABE4-4D09-B22D-3C37C65C8FC2Q30651444-9508BBA6-1689-4EB4-86A9-43B9763A6C21Q33509847-F3467E6D-A596-4668-B916-4A0FEF986F71Q33564132-B7745978-64AE-4FC7-8F94-BED32617B021Q33779797-D29C5A77-2BE8-48F1-97A9-A46BA1123980Q33786357-BD41D4F7-C55C-4834-9D4F-A040CF7FB29EQ33817401-B619977A-49D2-4637-80BF-0E807FC3FB09Q33822115-70CC5317-ADEE-46D6-A3B4-795DBA5A821DQ33868970-97C27A6D-D506-4761-BF4E-92A0BA15A1C7Q33916287-4D5ACB2C-02FD-4E29-85FE-436774ED9C3AQ33916329-BEEBE5AD-3826-46A1-B24F-9B7AB550F141Q33950898-106115F6-F10C-4AEC-826C-353BF59493B4Q34150651-FE74FC07-3AF8-4946-B121-E23431A20739Q34192660-EE03F8F5-C7FB-48BA-A457-7F0476AC88CFQ34275396-8B69D811-DA4D-42FC-A158-3FE9DFBE5853Q34378768-6A6DD35B-8773-4CCC-AF0F-B3A55B1C61C5Q34459879-594E10EA-97CA-40F1-B3A2-0E3AE9574182Q34617208-043CDE4C-5CD4-4637-8990-66387442FA55Q34663857-DDBF6A6D-1116-425D-B1D8-6AAA87A526CFQ34836490-6B65D424-F209-45F8-894E-4EB67904C30FQ35013983-D481676B-6451-4E53-A84B-1EA4900C79C4Q35061210-773D4E9D-0AEE-48C1-AA5F-CA865A08F480Q35100726-FFA99ABD-854A-4AE9-9FB1-314EA2AD5C7BQ35117320-13DC9E61-EDCA-4FDF-A52D-FA71EC0AD7F6Q35136001-2759C4AA-B7D1-4593-8296-A6E9FD22A2ADQ35142116-C2915AE4-5209-40EE-81C7-EA83A7DB2D89Q35193565-DE553121-C06B-43A6-A48E-90E49806A8D4Q35534959-2D5970F0-26EF-4E13-8354-B7536BAFA086
P2860
Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: a systematic review and metaanalysis of observational studies.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Effect of 5-aminosalicylate us ...... ysis of observational studies.
@ast
Effect of 5-aminosalicylate us ...... ysis of observational studies.
@en
type
label
Effect of 5-aminosalicylate us ...... ysis of observational studies.
@ast
Effect of 5-aminosalicylate us ...... ysis of observational studies.
@en
prefLabel
Effect of 5-aminosalicylate us ...... ysis of observational studies.
@ast
Effect of 5-aminosalicylate us ...... ysis of observational studies.
@en
P2093
P1476
Effect of 5-aminosalicylate us ...... ysis of observational studies.
@en
P2093
Fernando S Velayos
Jonathan P Terdiman
Judith M Walsh
P304
P356
10.1111/J.1572-0241.2005.41442.X
P407
P577
2005-06-01T00:00:00Z